CASC3 and acute lymphoblastic leukemia: In the present study, the anti-leukemic activity of CFZ was higher than that of BTZ in most of the BCP-ALL and T-ALL cell lines, and IKZF1 deletion was also associated with higher CFZ sensitivity in Ph-negative BCP-ALL cell lines.